HALOPERIDOL INTENSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Haloperidol Intensol, and what generic alternatives are available?
Haloperidol Intensol is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in HALOPERIDOL INTENSOL is haloperidol lactate. There are twenty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the haloperidol lactate profile page.
Summary for HALOPERIDOL INTENSOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 189 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HALOPERIDOL INTENSOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HALOPERIDOL INTENSOL
US Patents and Regulatory Information for HALOPERIDOL INTENSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | HALOPERIDOL INTENSOL | haloperidol lactate | CONCENTRATE;ORAL | 072045-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |